The invention concerns the use of coumarin or its hydroxy derivative, preferably 7-hydroxycoumarin, for the preparation of a medicament for the treatment of medium and severe lymphatic and/or vascular edema. The amount of coumarin or its hydroxy derivative is between 35 and 55 mg pro drug unit, preferably of 45 mg. The sublingual pharmaceutical form is described for the first time.
Use of coumarin or its hydroxy derivative for the treatment of medium or severe vascular
FRATTER A
2001
Abstract
The invention concerns the use of coumarin or its hydroxy derivative, preferably 7-hydroxycoumarin, for the preparation of a medicament for the treatment of medium and severe lymphatic and/or vascular edema. The amount of coumarin or its hydroxy derivative is between 35 and 55 mg pro drug unit, preferably of 45 mg. The sublingual pharmaceutical form is described for the first time.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
